The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

BACKGROUND: Clinical Treatment Score post-5 years (CTS5) is a promising prognostic tool to evaluate late distant recurrence (DR) risk for breast cancer after 5-year adjuvant endocrine therapy. PATIENTS AND METHODS: Among 560 postmenopausal women with pathological stage I–III estrogen receptor-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Wakako, Ijichi, Hideki, Takizawa, Katsumi, Koi, Yumiko, Masuda, Takanobu, Ueo, Hiroki, Koga, Chinami, Nakamura, Yoshiaki, Taguchi, Kenichi, Okamoto, Masahiro, Tokunaga, Eriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796868/
https://www.ncbi.nlm.nih.gov/pubmed/32601800
http://dx.doi.org/10.1007/s12282-020-01130-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796868/
https://www.ncbi.nlm.nih.gov/pubmed/32601800
http://dx.doi.org/10.1007/s12282-020-01130-y

Ejemplares similares